158 related articles for article (PubMed ID: 12683261)
1. Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications.
Mahadik SP; Evans DR
Psychiatr Clin North Am; 2003 Mar; 26(1):85-102. PubMed ID: 12683261
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.
Mahadik SP; Evans D; Lal H
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):463-93. PubMed ID: 11370992
[TBL] [Abstract][Full Text] [Related]
3. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.
Arvindakshan M; Sitasawad S; Debsikdar V; Ghate M; Evans D; Horrobin DF; Bennett C; Ranjekar PK; Mahadik SP
Biol Psychiatry; 2003 Jan; 53(1):56-64. PubMed ID: 12513945
[TBL] [Abstract][Full Text] [Related]
4. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
Khan MM; Evans DR; Gunna V; Scheffer RE; Parikh VV; Mahadik SP
Schizophr Res; 2002 Nov; 58(1):1-10. PubMed ID: 12363384
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
6. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
Mahadik SP; Pillai A; Joshi S; Foster A
Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
[TBL] [Abstract][Full Text] [Related]
7. Oxidative injury and potential use of antioxidants in schizophrenia.
Mahadik SP; Scheffer RE
Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):45-54. PubMed ID: 8888122
[TBL] [Abstract][Full Text] [Related]
8. Bioactive lipids in schizophrenia.
Berger GE; Smesny S; Amminger GP
Int Rev Psychiatry; 2006 Apr; 18(2):85-98. PubMed ID: 16777663
[TBL] [Abstract][Full Text] [Related]
9. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia.
Arvindakshan M; Ghate M; Ranjekar PK; Evans DR; Mahadik SP
Schizophr Res; 2003 Aug; 62(3):195-204. PubMed ID: 12837515
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics and phospholipid metabolism in schizophrenia].
Schmitt A; Maras A; Braus DF; Petroianu G; Jatzko A; Gattaz WF
Fortschr Neurol Psychiatr; 2001 Nov; 69(11):503-9. PubMed ID: 11704897
[TBL] [Abstract][Full Text] [Related]
11. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
12. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.
Fukuzako H; Fukuzako T; Takeuchi K; Ohbo Y; Ueyama K; Takigawa M; Fujimoto T
Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):629-40. PubMed ID: 8843487
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
[TBL] [Abstract][Full Text] [Related]
14. The membrane hypothesis of schizophrenia.
Horrobin DF; Glen AI; Vaddadi K
Schizophr Res; 1994 Oct; 13(3):195-207. PubMed ID: 7841132
[TBL] [Abstract][Full Text] [Related]
15. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
[TBL] [Abstract][Full Text] [Related]
16. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia.
Schmitt A; Maras A; Petroianu G; Braus DF; Scheuer L; Gattaz WF
J Neural Transm (Vienna); 2001; 108(8-9):1081-91. PubMed ID: 11716143
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.
Cansev M; Turkyilmaz M; Sijben JWC; Sevinc C; Broersen LM; van Wijk N
J Alzheimers Dis; 2017; 59(1):301-311. PubMed ID: 28598848
[TBL] [Abstract][Full Text] [Related]
18. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
Pettegrew JW; Keshavan MS; Minshew NJ
Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
[TBL] [Abstract][Full Text] [Related]
19. From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?
Skosnik PD; Yao JK
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):367-84. PubMed ID: 14623490
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol.
Bošković M; Vovk T; Koprivšek J; Plesničar BK; Grabnar I
Nutr Neurosci; 2016 May; 19(4):156-61. PubMed ID: 25056532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
